Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended BH4 Responsiveness in PKU
NCT04227080Phase 4Unknown
- Sponsor
- Taipei Veterans General Hospital
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
01
Overview
A Phase 4 trial of sapropterin in phenylketonuria (PKU), sponsored by Taipei Veterans General Hospital. Status: unknown.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT04227080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04227080.